Coronavirus Sars Articles & Analysis
12 articles found
Goal Understanding of Coronavirus (SARS-CoV-2) of interest using whole-genome sequence data from NCBI Solution Loci helps the scientists to understand the Coronavirus at the molecular level with a few click ...
Early in January 2020, sequencing revealed a novel coronavirus (now termed SARS-CoV-2) as the causal factor for the disease designated as COVID-19. ...
ByNuvonis
uenza, Vaccinia, Ross River, West Nile, Chikungunya, Tick-borne encephalitis virus (TBE), Hepatitis A, and SARS-Coronavirus including SARS CoV-2. ...
ByNuvonis
Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began in 2019 and rapidly scaled to a global presence of disease known as COVID-19. ...
The epidemic of respiratory pathogens has been bringing a huge disease burden to human beings, as in the case of the global pandemic of novel coronavirus (SARS-CoV-2), which has seriously affected world health and economic development. ...
While the world continues to endure loss and hardship due to the outbreak of COVID-19, caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers are scrambling to provide test kits that are accurate, fast, sensitive, and widely available, especially as symptoms vary broadly and may not appear for days if at all. ...
When the Pandemic Struck The coronavirus that caused the global COVID-19 pandemic is a positive sense, single stranded RNA beta coronavirus, a member of Beta-CoV lineage B (subgenus Sarbecovirus), possessing high likelihood for human-to-human transmission. ...
On January 8, 2022, Bloomberg reported that Leondios Kostrikis, a professor of biological sciences at the University of Cyprus, and his team had discovered a new variant of SARS-CoV-2, named "Deltacron" because it has an Omicron-like genetic signature in the Delta genome. ...
In response to the COVID-19 caused by the new coronavirus (SARS-CoV-2), there are currently many vaccines on the market worldwide. ...
Abstract Messenger RNA (mRNA) based vaccines (Pfizer/BioNTech and Moderna) are highly effective at providing immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is uncertainty about the duration of immunity, evolution of IgG antibody levels and IgG avidity (an index of antibody-antigen binding strength), and differences ...
The novel coronavirus continues to present a threat to business operations. Under the “new normal,” it’s crucial to implement higher levels of sanitation and ensure that your business can safely open. Unfortunately, there is a lot of misinformation spreading about both the virus itself and how to prevent its transmission. Here is a thorough overview of how to create an effective ...
ByAMPOL
Abstract Rationale:Patients with severe coronavirus disease (COVID-19) require supplemental oxygen and ventilatory support. It is unclear whether some respiratory support devices may increase the dispersion of infectious bioaerosols and thereby place healthcare workers at increased risk of infection with severe acute respiratory syndrome coronavirus 2 ...